FLUTIFORM 1255 Israel - English - Ministry of Health

flutiform 1255

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - pressurised suspention for inhalation - fluticasone propionate 0.125 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting β2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting β2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting β2 agonist.flutiform 125mcg/5mcg inhaler is indicated in adults and adolescents aged 12 years and above.

FLUTIFORM 25010 Israel - English - Ministry of Health

flutiform 25010

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - pressurised suspention for inhalation - fluticasone propionate 0.25 mg/dose; formoterol fumarate dihydrate 0.01 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting β2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting β2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting β2 agonist.flutiform 250mcg/10mcg inhaler is indicated in adults only.

Flutiform 50 microgram5 microgram per actuation pressurised inhalation suspension Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

flutiform 50 microgram5 microgram per actuation pressurised inhalation suspension

mundipharma pharmaceuticals sdn. bhd. - fluticasone propionate; formoterol fumarate -

Flutiform 125 microgram5 microgram per actuation pressurised inhalation suspension Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

flutiform 125 microgram5 microgram per actuation pressurised inhalation suspension

mundipharma pharmaceuticals sdn. bhd. - fluticasone propionate; formoterol fumarate -

Flutiform 250 microgram10 microgram per actuation pressurised inhalation suspension Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

flutiform 250 microgram10 microgram per actuation pressurised inhalation suspension

mundipharma pharmaceuticals sdn. bhd. - fluticasone propionate; formoterol fumarate -

Flutiform 50 µg - 5 µg press. inhal. susp. press. cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform 50 µg - 5 µg press. inhal. susp. press. cont.

mundipharma bv-srl - fluticasone propionate 0,05 mg; sodium cromoglicate 0,024 mg; formoterol fumarate dihydrate 0,005 mg - pressurised inhalation, suspension - 50 µg - 5 µg - fluticasone propionate 0.05 mg; formoterol fumarate dihydrate 5 µg - formoterol and fluticasone

Flutiform 125 µg - 5 µg press. inhal. susp. press. cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform 125 µg - 5 µg press. inhal. susp. press. cont.

mundipharma bv-srl - fluticasone propionate 0,125 mg; sodium cromoglicate 0,024 mg; formoterol fumarate dihydrate 0,005 mg - pressurised inhalation, suspension - 125 µg - 5 µg - fluticasone propionate 125 µg; formoterol fumarate dihydrate 5 µg - formoterol and fluticasone

Flutiform 250 µg - 10 µg press. inhal. susp. press. cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform 250 µg - 10 µg press. inhal. susp. press. cont.

mundipharma bv-srl - formoterol fumarate dihydrate 0,01 mg; fluticasone propionate 0,25 mg - pressurised inhalation, suspension - 250 µg - 10 µg - fluticasone propionate 0.25 mg; formoterol fumarate dihydrate 0.01 mg - formoterol and fluticasone

Flutiform K-haler 125 µg/dose - 5 µg/dose press. inhal. susp. inhaler Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform k-haler 125 µg/dose - 5 µg/dose press. inhal. susp. inhaler

mundipharma bv-srl - fluticasone propionate 0,125 mg/dose; formoterol fumarate dihydrate 0,005 mg/dose - pressurised inhalation, suspension - 125 µg/dose - 5 µg/dose - fluticasone propionate 0.125 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - formoterol and fluticasone

Flutiform K-haler 50 µg/dose - 5 µg/dose press. inhal. susp. inhaler Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform k-haler 50 µg/dose - 5 µg/dose press. inhal. susp. inhaler

mundipharma bv-srl - fluticasone propionate 0,05 mg/dose; formoterol fumarate dihydrate 0,005 mg/dose - pressurised inhalation, suspension - 50 µg/dose - 5 µg/dose - fluticasone propionate 0.05 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - formoterol and fluticasone